|
Appendix 4G and Corporate Governance Statement
|
30 June 2023 at 9:35am
|
|
Annual Report to Shareholders
|
30 June 2023 at 9:35am
|
|
Notice of AGM Date and Director Nomination Closing Date
|
7 June 2023 at 2:55pm
|
|
Investor Presentation
|
1 June 2023 at 10:15am
|
|
FY23 Full Year Results Presentation
|
31 May 2023 at 9:05am
|
|
FY23 Appendix 4E and Full Year Results
|
31 May 2023 at 9:05am
|
|
Notification of Full Year Results Webinar
|
24 May 2023 at 9:10am
|
|
Investor Presentation
|
27 April 2023 at 9:05am
|
|
March 2023 Quarterly Report and Appendix 4C
|
27 April 2023 at 9:05am
|
|
Notification of Quarterly Results Webinar
|
20 April 2023 at 9:00am
|
|
Notification regarding unquoted securities - ARX
|
12 April 2023 at 1:20pm
|
|
AROA secures first FDA clearance for ENIVO system
|
12 April 2023 at 9:30am
|
|
Release of Shares from Voluntary Escrow
|
4 April 2023 at 1:10pm
|
|
Change of Director's Interest Notice - SE
|
31 March 2023 at 3:15pm
|
|
Change of Director's Interest Notice - JP
|
31 March 2023 at 3:10pm
|
|
Change of Director's Interest Notice - JM
|
31 March 2023 at 3:10pm
|
|
Change of Director's Interest Notice - BW
|
31 March 2023 at 3:10pm
|
|
Change of Director's Interest Notice - PM
|
31 March 2023 at 3:10pm
|
|
Change of Director's Interest Notice - JD
|
31 March 2023 at 3:10pm
|
|
Notification regarding unquoted securities - ARX
|
31 March 2023 at 3:00pm
|
|
Aroa awarded agreement with Premier Inc
|
6 March 2023 at 9:15am
|
|
Application for quotation of securities - ARX
|
3 February 2023 at 3:15pm
|
|
Section 708A Notice
|
3 February 2023 at 3:10pm
|
|
Investor Presentation
|
31 January 2023 at 11:15am
|
|
December 2022 Quarterly Report and Appendix 4C
|
31 January 2023 at 9:35am
|
|
Notification of Quarterly Results Webinar
|
24 January 2023 at 10:25am
|
|
Notification of cessation of securities - ARX
|
12 January 2023 at 2:50pm
|
|
Notification of cessation of securities - ARX
|
11 January 2023 at 10:35am
|
|
Notification regarding unquoted securities - ARX
|
5 January 2023 at 10:55am
|
|
Change of Director's Interest Notice - JD
|
16 December 2022 at 10:50am
|
|
Notification regarding unquoted securities - ARX
|
16 December 2022 at 10:40am
|
|
Section 708A Notice
|
16 December 2022 at 10:40am
|
|
Application for quotation of securities - ARX
|
16 December 2022 at 10:40am
|
|
Notification regarding unquoted securities - ARX
|
12 December 2022 at 11:20am
|
|
Aroa Half Year Results Presentation
|
29 November 2022 at 11:20am
|
|
Aroa Biosurgery Half Yearly Results H1 FY23
|
29 November 2022 at 9:40am
|
|
Appendix 4D and Half Year Report
|
29 November 2022 at 9:35am
|
|
Notification regarding unquoted securities - ARX
|
28 November 2022 at 2:45pm
|
|
Appendix 3G
|
28 November 2022 at 2:45pm
|
|
Notification of Half Year Results Webinar
|
23 November 2022 at 9:55am
|
|
Initial Director's Interest Notice - CM
|
8 November 2022 at 2:15pm
|
|
Change of Registry Address
|
31 October 2022 at 4:25pm
|
|
Becoming a substantial holder
|
26 October 2022 at 1:40pm
|
|
Investor Presentation
|
25 October 2022 at 1:20pm
|
|
September 2022 Quarterly Report and Appendix 4C
|
25 October 2022 at 10:15am
|
|
Notification of Quarterly Webinar
|
19 October 2022 at 9:25am
|
|
Pre-Clinical Study of Enivo Shows Potential
|
18 October 2022 at 10:20am
|
|
Notification of cessation of securities - ARX
|
12 October 2022 at 1:35pm
|
|
Dr Catherine Mohr to join Aroa Board
|
13 September 2022 at 10:00am
|
|
Change of Director's Interest Notice - JD
|
2 September 2022 at 9:35am
|
